Advanced small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy with irinotecan and cisplatin followed by radical surgery

Small cell carcinoma of the uterine cervix is a rare form of cervical cancer characterized by extreme aggressiveness and poor prognosis because of its rapid growth, frequent distant metastases, and resistance to conventional treatment modalities. We report here a case of advanced-stage small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy, followed by radical surgery, resulting in locoregional disease control. A 39-year-old Japanese woman was diagnosed as having stage IIIb small cell carcinoma of the uterine cervix. She was treated by neoadjuvant chemotherapy with irinotecan/cisplatin, followed by extended radical hysterectomy with pelvic and paraaortic lymphadenectomy. The patient was further treated by adjuvant chemotherapy with irinotecan/cisplatin. Intrapelvic recurrence has not been detected throughout the postoperative course. However, the patient died with distant metastases of the disease, 27 months following the initial treatment. It has been suggested that neoadjuvant chemotherapy therapy followed by radical surgery is a treatment option for advanced-stage small cell carcinoma of the uterine cervix for the locoregional disease control. Further studies are necessary to obtain information regarding multimodal treatment including sequence, duration, frequency, and type of effective chemotherapy agents to be used in the treatment of small cell carcinoma of the uterine cervix

Mechanical properties of double-layer and graded composite coatings of YSZ obtained by atmospheric plasma spraying

Double-layer and graded composite coatings of yttria-stabilized zirconia were sprayed on metallic substrates by atmospheric plasma spray. The coating architecture was built up by combining two different feedstocks: one micro- and one nanostructured. Microstructural features and mechanical properties (hardness and elastic modulus) of the coatings were determined by FE-SEM microscopy and nanoindentation technique, respectively. Additional adherence and scratch tests were carried out in order to assess the failure mechanisms occurring between the layers comprising the composites. Microstructural inspection of the coatings confirms the two-zone microstructure. This bimodal microstructure which is exclusive of the layer obtained from the nanostructured feedstock negatively affects the mechanical properties of the whole composite. Nanoindentation tests suitably reproduce the evolution of mechanical properties through coatings thickness on the basis of the position and/or amount of nanostructured feedstock used in the depositing layer. Adhesion and scratch tests show the negative effect on the coating adhesion of layer obtained from the nanostructured feedstock when this layer is deposited on the bond coat. Thus, the poor integrity of this layer results in lower normal stresses required to delaminate the coating in the adhesion test as well as minor critical load registered by using the scratch test.This work has been supported by the Spanish Ministry of Science and Innovation (Project MAT2012-38364-C03) and co-funded by ERDF (European Regional Development Funds).Carpio-Cobo, P.; Rayón Encinas, E.; Salvador Moya, MD.; Lusvarghi, L.; Sanchez, E. (2016). Mechanical properties of double-layer and graded composite coatings of YSZ obtained by atmospheric plasma spraying. Journal of Thermal Spray Technology. 25(4):778-787. https://doi.org/10.1007/s11666-016-0390-zS778787254Y.S. Tian, C.Z. Chen, D.Y. Wang, and J.I. Quianmao, Recent Developments in Zirconia Thermal Barrier Coatings, Surf. Rev. Lett., 2005, 12, p 369-378S. Sampath, U. Schulz, M.O. Jarligo, and S. Kuroda, Processing Science of Advanced Thermal-Barrier Systems, MRS Bull., 2012, 37(10), p 903-910D.R. Clarke, M. Oeschsner, and N.P. Padture, Thermal-Barrier Coatings for More Efficient Gas-Turbine Engines, MRS Bull., 2012, 37(10), p 891-898A. Feuersein, J. Knapp, T. Taylor, A. Ashary, A. Bolcavage, and N. Hitchman, Technical and Economical Aspects of Current Thermal Barrier Coating Systems for Gas Turbine Engines by Thermal Spray and EBPVD: A Review, J. Therm. Spray Technol., 2008, 17(2), p 199-213R.S. Lima and B.R. Marple, Thermal Spray Coatings Engineered from Nanostructured Ceramic Agglomerated Powders for Structural, Thermal Barrier and Biomedical Applications: A Review, J. Therm. Spray Technol., 2007, 16(1), p 40-63P. Fauchais, G. Montavon, R.S. Lima, and B.R. Marple, Engineering a New Class of Thermal Spray Nano-based Microstructures from Agglomerated Nanostructured Particles, Suspensions and Solutions: An Invited Review, J. Phys. D Appl. Phys., 2011, 44(9), p 093001P. Carpio, Q. Blochet, B. Pateyron, L. Pawlowski, M.D. Salvador, A. Borrell, and E. Sánchez, Correlation of Thermal Conductivity of Suspension Plasma Sprayed Yttira Stabilized Zirconia Coatings with some Microstructural Effects, Mater. Lett., 2013, 107, p 370-373R. Vassen, A. Stuke, and D. Stöver, Recent Developments in the Field of Thermal Barrier Coatings, J. Therm. Spray Technol., 2009, 18(2), p 181-186H. Dai, X. Zhong, J. Li, Y. Zhang, J. Meng, and X. Cao, Thermal Stability of Double-Ceramic-Layer Thermal Barrier Coatings with Various Coating Thickness, Mater. Sci. Eng. A—Struct., 2006, 433(1), p 1–7V. Viswanathan, G. Dwivedi, and S. Sampath, Multimaterial Thermal Barrier Coating Systems: Design, Synthesis, and Performance Assessment, J. Am. Ceram. Soc., 2015, 98(6), p 1769-1777M. Saremi and Z. Valefi, Thermal and Mechanical Properties of Nano-YSZ-Alumina Functionally Graded Coatings Deposited by Nano-agglomerated Powder Plasma Spraying, Ceram. Int., 2014, 40(8), p 13453-13459A. Portinham, V. Teixeira, J. Carneiro, J. Martins, M.F. Costa, R. Vassen, and D. Stoever, Characterization of Thermal Barrier Coatings with a Gradient Porosity, Surf. Coat. Technol., 2005, 195(2), p 245-251P. Carpio, E. Bannier, M.D. Salvador, R. Benavente, and E. Sánchez, Multilayer and Particle Size-Graded YSZ Coatings Obtained by Plasma Spraying of Micro- and Nanostructured Feedstocks, J. Therm. Spray Technol., 2014, 23(8), p 1362-1372S. Nath, I. Manna, and J.D. Majumdar, Nanomechanical Behavior of Yttria Stabilized Zirconia (YSZ) Based Thermal Barrier Coating, Ceram. Int., 2015, 41(4), p 5247-5256P. Carpio, E. Rayón, L. Pawlowski, A. Cattini, R. Benavente, E. Bannier, M.D. Salvador, and E. Sánchez, Microstructure and Indentation Mechanical Properties of YSZ Nanostructured Coatings Obtained by Suspension Plasma Spraying, Surf. Coat. Technol., 2013, 220, p 237-243H.B. Guo, H. Murakami, and S. Kuroda, Effect of Hollow Spherical Powder Size Distribution on Porosity and Segmentation Cracks in Thermal Barrier Coatings, J. Am. Ceram. Soc., 2006, 89(12), p 3797-3804R.S. Lima, A. Kucuk, and C.C. Berndt, Integrity of Nanostructured Partially Stabilized Zirconia After Plasma Spray Processing, Mater. Sci. Eng. A, 2001, 313(1), p 75-82E. Rayón, V. Bonache, M.D. Salvador, and E. Sánchez, Hardness and Young’s Modulus Distributions in Atmospheric Plasma Sprayed WC-Co Coatings Using Nanoindentation, Surf. Coat. Technol., 2011, 205(17), p 4192-4197J.A. Wollmershauser, B.N. Feigelson, E.P. Gorzkowski, C.T. Ellis, R. Goswami, S.B. Qadri, J.G. Tischler, F.J. Kub, and R.K. Everett, An Extend Hardness Limit in Bulk Nanoceramics, Acta Mater., 2014, 69, p 9-16L. Wang, Y. Wang, X.G. Sun, J.Q. He, Z.Y. Pan, and C.H. Wang, Microstructure and Indentation Mechanical Properties of Plasma Sprayed Nano-Bimodal and Conventional ZrO2-8 wt% Y2O3 Thermal Barrier Coatings, Vacuum, 2012, 86(8), p 1174-1185G.S. Barroso, W. Krenkel, and G. Motz, Low Thermal Conductivity Coating System for Application up to 1000 °C by Simple PDC Processing with Active and Passive Fillers, J. Eur. Ceram. Soc., 2015, 35(12), p 3339-3348R. Ghasemi, R. Shoja-Razavi, R. Mozafarinia, H. Jamali, M. Hajizadh-Oghaz, and R. Ahmadi-Pidani, The Influence of Laser Treatment on Hot Corrosion Behavior of Plasma-Sprayed Nanostructured Yttria Stabilized Zirconia Thermal Barrier Coatings, J. Eur. Ceram. Soc., 2014, 34(8), p 2013-2021E. Rayón, V. Bonache, M.D. Salvador, E. Bannier, E. Sánchez, A. Denoirjean, and H. Ageorges, Nanoindentation Study of the Mechanical and Damage Behaviour of Suspension Plasma Sprayed TiO2 Coatings, Surf. Coat. Technol., 2012, 206(10), p 2655-2660J.J. Roa, E. Jiménez-Piqué, R. Martínez, G. Ramírez, J.M. Tarragó, R. Rodríguez, and L. Llanes, Contact Damage and Fracture Micromechanisms of Multilayered TiN/CrN Coatings at Micro- and Nano-length Scales, Thin Solid Films, 2014, 571(2), p 308-31

Eye movements and reading in glaucoma: observations on patients with advanced visual field loss

Purpose To investigate the relationship between reading speed and eye movements in patients with advanced glaucomatous visual field (VF) defects and age-similar visually healthy people. Methods Eighteen patients with advanced bilateral VF defects (mean age: 71, standard deviation [SD]: 7 years) and 39 controls (mean age: 67, SD: 8 years) had reading speed measured using short passages of text on a computer set-up incorporating eye tracking. Scanpaths were plotted and analysed from these experiments to derive measures of ‘perceptual span’ (total number of letters read per number of saccades) and ‘text saturation’ (the distance between the first and last fixation on lines of text). Another eye movement measure, termed ‘saccadic frequency’ (total number of saccades made to read a single word), was derived from a separate lexical decision task, where words were presented in isolation. Results Significant linear association was demonstrated between perceptual span and reading speed in patients (R2=0.42) and controls (R2=0.56). Linear association between saccadic frequency during the LDT and reading speed was also found in patients (R2=0.42), but not in controls (R2=0.02). Patients also exhibited greater average text saturation than controls (P=0.004). Conclusion Some, but not all, patients with advanced VF defects read slower than controls using short text passages. Differences in eye movement behaviour may partly account for this variability in patients. These patients were shown to saturate lines of text more during reading, which may explain previously-reported difficulties with sustained reading

DAZL Relieves miRNA-Mediated Repression of Germline mRNAs by Controlling Poly(A) Tail Length in Zebrafish

BACKGROUND:During zebrafish embryogenesis, microRNA (miRNA) miR-430 contributes to restrict Nanos1 and TDRD7 to primordial germ cells (PGCs) by inducing mRNA deadenylation, mRNA degradation, and translational repression of nanos1 and tdrd7 mRNAs in somatic cells. The nanos1 and tdrd7 3'UTRs include cis-acting elements that allow activity in PGCs even in the presence of miRNA-mediated repression. METHODOLOGY/PRINCIPAL FINDINGS:Using a GFP reporter mRNA that was fused with tdrd7 3'UTR, we show that a germline-specific RNA-binding protein DAZ-like (DAZL) can relieve the miR-430-mediated repression of tdrd7 mRNA by inducing poly(A) tail elongation (polyadenylation) in zebrafish. We also show that DAZL enhances protein synthesis via the 3'UTR of dazl mRNA, another germline mRNA targeted by miR-430. CONCLUSIONS/SIGNIFICANCE:Our present study indicated that DAZL acts as an "anti-miRNA factor" during vertebrate germ cell development. Our data also suggested that miRNA-mediated regulation can be modulated on specific target mRNAs through the poly(A) tail control

Fabrication of Worm-Like Nanorods and Ultrafine Nanospheres of Silver Via Solid-State Photochemical Decomposition

Worm-like nanorods and nanospheres of silver have been synthesized by photochemical decomposition of silver oxalate in water by UV irradiation in the presence of CTAB and PVP, respectively. No external seeds have been employed for the synthesis of Ag nanorods. The synthesized Ag colloids have been characterized by UV-visible spectra, powder XRD, HRTEM, and selected area electron diffraction (SAED). Ag nanospheres of average size around 2 nm have been obtained in the presence of PVP. XRD and TEM analyses revealed that top and basal planes of nanorods are bound with {111} facets. Williamson–Hall plot has revealed the presence of defects in the Ag nanospheres and nanorods. Formation of defective Ag nanocrystals is attributed to the heating effect of UV-visible irradiation

Eye movements during visual search in patients with glaucoma

Background: Glaucoma has been shown to lead to disability in many daily tasks including visual search. This study aims to determine whether the saccadic eye movements of people with glaucoma differ from those of people with normal vision, and to investigate the association between eye movements and impaired visual search. Methods: Forty patients (mean age: 67 [SD: 9] years) with a range of glaucomatous visual field (VF) defects in both eyes (mean best eye mean deviation [MD]: –5.9 (SD: 5.4) dB) and 40 age-related people with normal vision (mean age: 66 [SD: 10] years) were timed as they searched for a series of target objects in computer displayed photographs of real world scenes. Eye movements were simultaneously recorded using an eye tracker. Average number of saccades per second, average saccade amplitude and average search duration across trials were recorded. These response variables were compared with measurements of VF and contrast sensitivity. Results: The average rate of saccades made by the patient group was significantly smaller than the number made by controls during the visual search task (P = 0.02; mean reduction of 5.6% (95% CI: 0.1 to 10.4%). There was no difference in average saccade amplitude between the patients and the controls (P = 0.09). Average number of saccades was weakly correlated with aspects of visual function, with patients with worse contrast sensitivity (PR logCS; Spearman’s rho: 0.42; P = 0.006) and more severe VF defects (best eye MD; Spearman’s rho: 0.34; P = 0.037) tending to make less eye movements during the task. Average detection time in the search task was associated with the average rate of saccades in the patient group (Spearman’s rho = −0.65; P < 0.001) but this was not apparent in the controls. Conclusions: The average rate of saccades made during visual search by this group of patients was fewer than those made by people with normal vision of a similar average age. There was wide variability in saccade rate in the patients but there was an association between an increase in this measure and better performance in the search task. Assessment of eye movements in individuals with glaucoma might provide insight into the functional deficits of the disease

Post-transcriptional control of tumor cell autonomous metastatic potential by the CCR4-NOT deadenylase CNOT7

Accumulating evidence supports the role of an aberrant transcriptome as a driver of metastatic potential. Deadenylation is a general regulatory node for post-transcriptional control by microRNAs and other determinants of RNA stability. Previously, we demonstrated that the CCR4-NOT scaffold component Cnot2 is an inherited metastasis susceptibility gene. In this study, using orthotopic metastasis assays and genetically engineered mouse models, we show that one of the enzymatic subunits of the CCR4-NOT complex, Cnot7, is also a metastasis modifying gene. We demonstrate that higher expression of Cnot7 drives tumor cell autonomous metastatic potential, which requires its deadenylase activity. Furthermore, metastasis promotion by CNOT7 is dependent on interaction with CNOT1 and TOB1. CNOT7 ribonucleoprotein-immunoprecipitation (RIP) and integrated transcriptome wide analyses reveal that CNOT7-regulated transcripts are enriched for a tripartite 3’UTR motif bound by RNA-binding proteins known to complex with CNOT7, TOB1, and CNOT1. Collectively, our data support a model of CNOT7, TOB1, CNOT1, and RNA-binding proteins collectively exerting post-transcriptional control on a metastasis suppressive transcriptional program to drive tumor cell metastasis

Targeting medication non-adherence behavior in selected autoimmune diseases: a systematic approach to digital health program development

Background 29 autoimmune diseases, including Rheumatoid Arthritis, gout, Crohn’s Disease, and Systematic Lupus Erythematosus affect 7.6-9.4% of the population. While effective therapy is available, many patients do not follow treatment or use medications as directed. Digital health and Web 2.0 interventions have demonstrated much promise in increasing medication and treatment adherence, but to date many Internet tools have proven disappointing. In fact, most digital interventions continue to suffer from high attrition in patient populations, are burdensome for healthcare professionals, and have relatively short life spans. Objective Digital health tools have traditionally centered on the transformation of existing interventions (such as diaries, trackers, stage-based or cognitive behavioral therapy programs, coupons, or symptom checklists) to electronic format. Advanced digital interventions have also incorporated attributes of Web 2.0 such as social networking, text messaging, and the use of video. Despite these efforts, there has not been little measurable impact in non-adherence for illnesses that require medical interventions, and research must look to other strategies or development methodologies. As a first step in investigating the feasibility of developing such a tool, the objective of the current study is to systematically rate factors of non-adherence that have been reported in past research studies. Methods Grounded Theory, recognized as a rigorous method that facilitates the emergence of new themes through systematic analysis, data collection and coding, was used to analyze quantitative, qualitative and mixed method studies addressing the following autoimmune diseases: Rheumatoid Arthritis, gout, Crohn’s Disease, Systematic Lupus Erythematosus, and inflammatory bowel disease. Studies were only included if they contained primary data addressing the relationship with non-adherence. Results Out of the 27 studies, four non-modifiable and 11 modifiable risk factors were discovered. Over one third of articles identified the following risk factors as common contributors to medication non-adherence (percent of studies reporting): patients not understanding treatment (44%), side effects (41%), age (37%), dose regimen (33%), and perceived medication ineffectiveness (33%). An unanticipated finding that emerged was the need for risk stratification tools (81%) with patient-centric approaches (67%). Conclusions This study systematically identifies and categorizes medication non-adherence risk factors in select autoimmune diseases. Findings indicate that patients understanding of their disease and the role of medication are paramount. An unexpected finding was that the majority of research articles called for the creation of tailored, patient-centric interventions that dispel personal misconceptions about disease, pharmacotherapy, and how the body responds to treatment. To our knowledge, these interventions do not yet exist in digital format. Rather than adopting a systems level approach, digital health programs should focus on cohorts with heterogeneous needs, and develop tailored interventions based on individual non-adherence patterns

Are we ready for genetic testing for primary open-angle glaucoma?

Following a dramatic reduction in the cost of genotyping technology in recent years, there have been significant advances in the understanding of the genetic basis of glaucoma. Glaucoma patients represent around a quarter of all outpatient activity in the UK hospital eye service and are a huge burden for the National Health Service. A potential benefit of genetic testing is personalised glaucoma management, allowing direction of our limited healthcare resources to the glaucoma patients who most need it. Our review aims to summarise recent discoveries in the field of glaucoma genetics and to discuss their potential clinical utility. While genome-wide association studies have now identified over ten genes associated with primary open-angle glaucoma (POAG), individually, variants in these genes are not predictive of POAG in populations. There are data suggesting some of these POAG variants are associated with conversion from ocular hypertension to POAG and visual field progression among POAG patients. However, these studies have not been replicated yet and such genetic testing is not currently justified in clinical care. In contrast, genetic testing for inherited early-onset disease in relatives of POAG patients with a known genetic mutation is of clear benefit; this can support either regular review to commence early treatment when the disease develops, or discharge from ophthalmology services of relatives who do not carry the mutation. Genetic testing for POAG at a population level is not currently justified